These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 31926466)

  • 21. Suvorexant (Belsomra) for insomnia.
    Med Lett Drugs Ther; 2015 Mar; 57(1463):29-31. PubMed ID: 25719996
    [No Abstract]   [Full Text] [Related]  

  • 22. Suvorexant for insomnia: a systematic review of the efficacy and safety profile for this newly approved hypnotic - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
    Citrome L
    Int J Clin Pract; 2014 Dec; 68(12):1429-41. PubMed ID: 25231363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suvorexant-Induced Dream Enactment Behavior in Parkinson Disease: A Case Report.
    Tabata H; Kuriyama A; Yamao F; Kitaguchi H; Shindo K
    J Clin Sleep Med; 2017 May; 13(5):759-760. PubMed ID: 28212694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suvorexant: efficacy and safety profile of a dual orexin receptor antagonist in treating insomnia.
    Owen RT
    Drugs Today (Barc); 2016 Jan; 52(1):29-40. PubMed ID: 26937493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of Dimdazenil in adults with insomnia disorder: results from a multicenter, randomized, double-blind, placebo-controlled phase III trials.
    Huang Z; Zhan S; Chen C; Zhang R; Zhou Y; He J; Lin Z; Bao C; Zhu S; Zhao J; Zhang S; Jiang Y; Wang Y
    Sleep; 2024 Feb; 47(2):. PubMed ID: 37875349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced slow wave sleep and improved sleep maintenance after gaboxadol administration during seven nights of exposure to a traffic noise model of transient insomnia.
    Dijk DJ; Stanley N; Lundahl J; Groeger JA; Legters A; Trap Huusom AK; Deacon S
    J Psychopharmacol; 2012 Aug; 26(8):1096-107. PubMed ID: 22002961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Home is where sleep is: an ecological approach to test the validity of actigraphy for the assessment of insomnia.
    Sánchez-Ortuño MM; Edinger JD; Means MK; Almirall D
    J Clin Sleep Med; 2010 Feb; 6(1):21-9. PubMed ID: 20191934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suvorexant approved for insomnia.
    Traynor K
    Am J Health Syst Pharm; 2014 Sep; 71(18):1524. PubMed ID: 25174007
    [No Abstract]   [Full Text] [Related]  

  • 29. Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials.
    Herring WJ; Connor KM; Ivgy-May N; Snyder E; Liu K; Snavely DB; Krystal AD; Walsh JK; Benca RM; Rosenberg R; Sangal RB; Budd K; Hutzelmann J; Leibensperger H; Froman S; Lines C; Roth T; Michelson D
    Biol Psychiatry; 2016 Jan; 79(2):136-48. PubMed ID: 25526970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suvorexant (Belsomra) for Insomnia.
    Gauld AR
    Am Fam Physician; 2016 Jun; 93(12):1016-20. PubMed ID: 27304771
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of short-term treatment with gaboxadol on sleep maintenance and initiation in patients with primary insomnia.
    Deacon S; Staner L; Staner C; Legters A; Loft H; Lundahl J
    Sleep; 2007 Mar; 30(3):281-7. PubMed ID: 17425224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Orexin receptor antagonism for treatment of insomnia: a randomized clinical trial of suvorexant.
    Herring WJ; Snyder E; Budd K; Hutzelmann J; Snavely D; Liu K; Lines C; Roth T; Michelson D
    Neurology; 2012 Dec; 79(23):2265-74. PubMed ID: 23197752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of suvorexant, an orexin receptor antagonist, on breathing during sleep in patients with chronic obstructive pulmonary disease.
    Sun H; Palcza J; Rosenberg R; Kryger M; Siringhaus T; Rowe J; Lines C; Wagner JA; Troyer MD
    Respir Med; 2015 Mar; 109(3):416-26. PubMed ID: 25661282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suvorexant in the Treatment of Difficulty Falling and Staying Asleep (Insomnia).
    Berger AA; Sottosanti ER; Winnick A; Keefe J; Gilbert E; Hasoon J; Thase ME; Kaye AD; Viswanath O; Urits I
    Psychopharmacol Bull; 2022 Feb; 52(1):68-90. PubMed ID: 35342199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alterations in cyclic alternating pattern associated with phase advanced sleep are differentially modulated by gaboxadol and zolpidem.
    Svetnik V; Ferri R; Ray S; Ma J; Walsh JK; Snyder E; Ebert B; Deacon S
    Sleep; 2010 Nov; 33(11):1562-70. PubMed ID: 21102998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relation between ambulatory actigraphy and laboratory polysomnography in insomnia practice and research.
    Withrow D; Roth T; Koshorek G; Roehrs T
    J Sleep Res; 2019 Aug; 28(4):e12854. PubMed ID: 30941838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Preclinical and clinical results of dual orexin receptor antagonist, suvorexant (BELSOMRA(®)), a novel therapeutic agent for insomnia].
    Tanaka Y; Aoki I; Ishine T; Renger JJ; Winrow CJ; Hisada S
    Nihon Yakurigaku Zasshi; 2016 Jul; 148(1):46-56. PubMed ID: 27430679
    [No Abstract]   [Full Text] [Related]  

  • 38. Prescription Drugs Used in Insomnia.
    Dujardin S; Pijpers A; Pevernagie D
    Sleep Med Clin; 2020 Jun; 15(2):133-145. PubMed ID: 32386689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The exploratory power of sleep effort, dysfunctional beliefs and arousal for insomnia severity and polysomnography-determined sleep.
    Hertenstein E; Nissen C; Riemann D; Feige B; Baglioni C; Spiegelhalder K
    J Sleep Res; 2015 Aug; 24(4):399-406. PubMed ID: 25773981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perception of sleep in recovering alcohol-dependent patients with insomnia: relationship with future drinking.
    Conroy DA; Todd Arnedt J; Brower KJ; Strobbe S; Consens F; Hoffmann R; Armitage R
    Alcohol Clin Exp Res; 2006 Dec; 30(12):1992-9. PubMed ID: 17117964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.